Literature DB >> 17691036

Neuropsychological evaluation of the treatments applied to intracranial aneurysms in a Spanish sample.

Sandra Santiago-Ramajo1, Majed J Katati, Miguel Pérez-García, M Angeles Coín-Mejias, Raquel Vilar-Lopez, Alfonso Caracuel-Romero, Ventura Arjona-Moron.   

Abstract

Very few studies have examined the neuropsychological differences between the two types of aneurysm treatment, and these studies come from different countries. The purpose of this study is to compare the neuropsychological differences between surgical treatment and endovascular treatment in a Spanish sample of patients who have experienced an aneurysmal subarachnoid hemorrhage. The sample is composed of three groups: 40 patients who underwent surgical intervention, 24 who were treated by means of coiling, and a group of 29 healthy participants. An extensive neuropsychological evaluation was performed. The results presented show that no neuropsychological differences were found between the two types of treatment for aneurysms and that the most affected function was memory. This result coincides with findings from other studies.

Entities:  

Mesh:

Year:  2007        PMID: 17691036     DOI: 10.1080/13803390600879024

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  3 in total

1.  Transcranial Doppler for Early Prediction of Cognitive Impairment after Aneurysmal Subarachnoid Hemorrhage and the Associated Clinical Biomarkers.

Authors:  Ahmed Esmael; Tamer Belal; Khaled Eltoukhy
Journal:  Stroke Res Treat       Date:  2020-11-23

2.  RECOVERY OF MEMORY AFTER CEREBRAL ARTERY ANEURYSM SURGERY.

Authors:  Ljiljana Pačić-Turk; Petra Jandrijević; Ana Havelka-Meštrović
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.932

Review 3.  Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage.

Authors:  Hyojin Jeon; Jinglu Ai; Mohamed Sabri; Asma Tariq; Xueyuan Shang; Gang Chen; R Loch Macdonald
Journal:  BMC Neurosci       Date:  2009-08-25       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.